Storia in 2 fonti

Why Is Biohaven Stock Soaring Wednesday? - Biohaven (NYSE:BHVN)

Biohaven gains $795M in global licensing deal and $4M lawsuit win. BHVN jumps 13% as William Blair eyes upcoming trial data.

Raccontata da

biopharmadive.com

benzinga.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

benzinga.comStai leggendo3 g fa

Why Is Biohaven Stock Soaring Wednesday? - Biohaven (NYSE:BHVN)

Biohaven gains $795M in global licensing deal and $4M lawsuit win. BHVN jumps 13% as William Blair eyes upcoming trial data.

originale

biopharmadive.com4 g fa

Biohaven trades cash for ‘upside’ with $795M epilepsy drug deal

Faced with a dwindling bank account after a series of research setbacks, Biohaven is letting go of its most advanced experimental drug in a deal one analyst viewed as a “surprising” transaction.

Leggi questa versione → originale

Timeline cronologica

mercoledì 26 agosto 2026·biopharmadive.com
Biohaven trades cash for ‘upside’ with $795M epilepsy drug deal
Faced with a dwindling bank account after a series of research setbacks, Biohaven is letting go of its most advanced experimental drug in a deal one analyst viewed as a…
mercoledì 26 agosto 2026·benzinga.com
Why Is Biohaven Stock Soaring Wednesday? - Biohaven (NYSE:BHVN)
Biohaven gains $795M in global licensing deal and $4M lawsuit win. BHVN jumps 13% as William Blair eyes upcoming trial data.